469 related articles for article (PubMed ID: 8756921)
1. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
3. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
4. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
[TBL] [Abstract][Full Text] [Related]
5. Primary and revision efficacy of cross-wired metallic stents for endoscopic bilateral stent-in-stent placement in malignant hilar biliary strictures.
Lee TH; Moon JH; Kim JH; Park DH; Lee SS; Choi HJ; Cho YD; Park SH; Kim SJ
Endoscopy; 2013; 45(2):106-13. PubMed ID: 23212727
[TBL] [Abstract][Full Text] [Related]
6. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
7. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
9. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
10. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses.
Peters RA; Williams SG; Lombard M; Karani J; Westaby D
Endoscopy; 1997 Jan; 29(1):10-6. PubMed ID: 9083730
[TBL] [Abstract][Full Text] [Related]
11. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.
Freeman ML; Overby C
Gastrointest Endosc; 2003 Jul; 58(1):41-9. PubMed ID: 12838219
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
13. Malignant obstruction of the common bile duct: long-term results of Gianturco-Rosch metal stents used as initial treatment.
Mathieson JR; McLoughlin RF; Cooperberg PL; Prystai CC; Stordy SN; MacFarlane JK; Schmidt N
Radiology; 1994 Sep; 192(3):663-7. PubMed ID: 7520181
[TBL] [Abstract][Full Text] [Related]
14. Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study.
Hwang JC; Kim JH; Lim SG; Kim SS; Yoo BM; Cho SW
Scand J Gastroenterol; 2011 Mar; 46(3):326-32. PubMed ID: 21082874
[TBL] [Abstract][Full Text] [Related]
15. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction.
Saleem A; Leggett CL; Murad MH; Baron TH
Gastrointest Endosc; 2011 Aug; 74(2):321-327.e1-3. PubMed ID: 21683354
[TBL] [Abstract][Full Text] [Related]
17. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation.
Bruha R; Petrtyl J; Kubecova M; Marecek Z; Dufek V; Urbanek P; Kodadova J; Chodounsky Z
Hepatogastroenterology; 2001; 48(39):631-7. PubMed ID: 11462891
[TBL] [Abstract][Full Text] [Related]
18. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
19. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]